# The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

> **NCT04207736** · PHASE3 · COMPLETED · sponsor: **Aldeyra Therapeutics, Inc.** · enrollment: 95 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Reproxalap Ophthalmic Solution (0.25%)
- **DRUG:** Vehicle Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04207736
- **Lead sponsor:** Aldeyra Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-05
- **Primary completion:** 2021-02-16
- **Final completion:** 2021-02-16
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04207736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04207736, "The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04207736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*